Trial Search Results
The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers
In patients with cancer of the head and neck and rectum, knowing the exact location of the tumor is important for designing the radiation field to ensure delivery of high dose of radiation to the tumor while sparing surrounding normal tissues. A new medical imaging method which is a combination of positron emission tomography (PET) and computed tomography (CT) scan, has shown promise in helping the radiation oncologist in defining the exact location and extent of the tumor in certain cancers such as lung cancers. Therefore the purpose of this study is to determine if these imaging methods can be used in combination with the standard radiation treatment planning procedure to improve the accuracy to targeting your tumor with radiation. In addition the PET-CT scan, similar to the PET scan alone with better resolution, can be used to determine whether the tumor has spread to any part of the body outside of the head and neck sites.
Stanford is currently not accepting patients for this trial.
Collaborator: McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
- Procedure: PET-CT
Inclusion Criteria:Patients who are scheduled to receive radiation therapy for head and
neck cancer at Stanford.
Exclusion Criteria:Non-Stanford patients.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study